EP Patent

EP3061760A1 — Deuterated benzoquinolizine derivatives as inhibitors of vesicular monoamine transporter 2

Assigned to Auspex Pharmaceuticals Inc · Expires 2016-08-31 · 10y expired

What this patent protects

A compound of structural Formula I or a salt thereof: for use in the treatment of a chronic hyperkinetic movement disorder.

USPTO Abstract

A compound of structural Formula I or a salt thereof: for use in the treatment of a chronic hyperkinetic movement disorder.

Drugs covered by this patent

Patent Metadata

Patent number
EP3061760A1
Jurisdiction
EP
Classification
—
Expires
2016-08-31
Drug substance claim
No
Drug product claim
No
Assignee
Auspex Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.